Advertisement
UK markets closed
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • FTSE 250

    19,824.16
    +222.18 (+1.13%)
     
  • AIM

    755.28
    +2.16 (+0.29%)
     
  • GBP/EUR

    1.1679
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2494
    -0.0017 (-0.13%)
     
  • Bitcoin GBP

    51,107.49
    -604.23 (-1.17%)
     
  • CMC Crypto 200

    1,327.81
    -68.72 (-4.92%)
     
  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     
  • DOW

    38,239.66
    +153.86 (+0.40%)
     
  • CRUDE OIL

    83.66
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,349.60
    +7.10 (+0.30%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     
  • DAX

    18,161.01
    +243.73 (+1.36%)
     
  • CAC 40

    8,088.24
    +71.59 (+0.89%)
     

20 Democratic senators blast steep price hike for EpiPens

FILE - In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. Mylan said it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine. (AP Photo/Rich Pedroncelli, File)
FILE - In this July 8, 2016, file photo, a pharmacist holds a package of EpiPens epinephrine auto-injector, a Mylan product, in Sacramento, Calif. Mylan said it will make available a generic version of its EpiPen, as criticism mounts over the price of its injectable medicine. (AP Photo/Rich Pedroncelli, File)

http://syndication.ap.org/AP.Distro.ContentBroker2/ContentBroker.aspx?contentid=7b663d1d22864bee8f421e38768e763d&iid=45886c370ef740699dd4810279474943&rsn=1&recordid=f6613b480cbf4b34892afea5421f990d&filingId=c2df8e6e9d4d4c8d8c5d98eaf2192c44&role=Preview&reldt=2016-08-29T12:47:27&media=Photo&sz=52588&dest=ak&trF=NY108&ofn=Mylan%2bEpiPen.JPEG&fmt=jpg&relativeUrl=jpg/2016/201608/29/7b663d1d22864bee8f421e38768e763d.jpg&s3Key=versions/preview-v01.jpg&authToken=eNotizEOwyAMAF8EMhgcFqS%2bBXAlDw0RBLWDHx%2bGLrfcnfIvExKkgMEFAgAERK2Sj0KEzTXjfSITCrNJ7%2bCNY0wHJT621S5t7xBR18y1n%2feQsu4%2b5qusKSfPjSmNh639o0t27IBQr2%2f%2bCxdB5crRW7LeeZviA4ILLVE%3d

WASHINGTON (AP) — Twenty Democratic senators are demanding answers about steep price hikes for the life-saving EpiPen injector device.

The senators said in a letter to the CEO of pharmaceutical company that makes the devices, Mylan N.V., that price hikes of more than 500 percent have jeopardized access to emergency allergy shots for many Americans. The letter was addressed to Heather Bresch, daughter of Democratic Sen. Joe Manchin of West Virginia. Manchin did not sign the letter.

ADVERTISEMENT

Mylan has responded to the public outcry by expanding programs to make EpiPens more affordable and promising a cheaper, generic version.

But the senators who signed the letter say the generic device still costs three times more than the branded EpiPen did in 2007. They are asking Mylan to answer detailed questions by Sept. 12.

See Also: